Home ›
Kidney Cancer Trials ›
NCT05842044
NSAID Use After Robotic Partial Nephrectomy
The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Trial Details
NCT ID NCT05842044
Phase PHASE2
Sponsor University of Miami
Status RECRUITING
Cancer Type Kidney Cancer
Interventions Ketorolac Acetaminophen Oxycodone Hydromorphone Ibuprofen
Locations (sample) Miami, Florida, United States|25.77427,-80.19366
Key Eligibility Criteria
Patients undergoing uncomplicated robotic assisted laparoscopic partial nephrectomy for renal mass at the University of Miami Hospital and Network … Age 18-99. Ability to understand and the willingness to sign a written informed consent document.
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Kidney Cancer Trials on Trialify →